Mark Schiffman

87.0k total citations · 15 hit papers
429 papers, 37.4k citations indexed

About

Mark Schiffman is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Mark Schiffman has authored 429 papers receiving a total of 37.4k indexed citations (citations by other indexed papers that have themselves been cited), including 386 papers in Epidemiology, 171 papers in Surgery and 108 papers in Oncology. Recurrent topics in Mark Schiffman's work include Cervical Cancer and HPV Research (380 papers), Genital Health and Disease (155 papers) and Global Cancer Incidence and Screening (75 papers). Mark Schiffman is often cited by papers focused on Cervical Cancer and HPV Research (380 papers), Genital Health and Disease (155 papers) and Global Cancer Incidence and Screening (75 papers). Mark Schiffman collaborates with scholars based in United States, Costa Rica and France. Mark Schiffman's co-authors include Philip E. Castle, Sholom Wacholder, Diane Solomon, Nicolas Wentzensen, Ana Cecilia Rodríguez, José Jerónimo, Mark E. Sherman, Robert D. Burk, Rolando Herrero and M. Michele Manos and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Mark Schiffman

426 papers receiving 36.2k citations

Hit Papers

Prevalence of Human Papillomavirus in Cervical Cancer: a ... 1993 2026 2004 2015 1995 2007 2012 1993 2005 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
    1995 2.8k citations Mark Schiffman et al. JNCI Journal of the National Cancer Institute profile →
  2. Human papillomavirus and cervical cancer
    2007 2.1k citations Mark Schiffman, Philip E. Castle et al. profile →
  3. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
    2012 1.0k citations Diane Solomon, Nicolas Wentzensen et al. profile →
  4. Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia
    1993 986 citations Mark Schiffman, Brenda B. Rush et al. JNCI Journal of the National Cancer Institute profile →
  5. The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice
    2005 806 citations Philip E. Castle, Attila T. Lörincz et al. JNCI Journal of the National Cancer Institute profile →
  6. Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
    2013 776 citations Mark Schiffman et al. JNCI Journal of the National Cancer Institute profile →
  7. Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized Trial
    2001 757 citations Mark Schiffman et al. JNCI Journal of the National Cancer Institute profile →
  8. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
    2012 745 citations Diane Solomon, Nicolas Wentzensen et al. Journal of Lower Genital Tract Disease profile →
  9. Carcinogenic human papillomavirus infection
    2016 642 citations Mark Schiffman, Nicolas Wentzensen et al. profile →
  10. Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
    2008 634 citations Mark Schiffman et al. profile →
  11. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
    2012 613 citations Diane Solomon, Nicolas Wentzensen et al. profile →
  12. Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
    1994 581 citations Allan Hildesheim, Mark Schiffman et al. profile →
  13. Human Papillomavirus Testing in the Prevention of Cervical Cancer
    2011 554 citations Mark Schiffman, Nicolas Wentzensen et al. JNCI Journal of the National Cancer Institute profile →
  14. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
    2011 412 citations Hormuzd A. Katki, Walter Kinney et al. profile →
  15. Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
    2013 350 citations Rolando Herrero, Wim Quint et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Schiffman United States 93 31.7k 14.1k 8.2k 6.5k 4.8k 429 37.4k
Rolando Herrero United States 95 23.4k 0.7× 11.9k 0.8× 5.8k 0.7× 4.4k 0.7× 4.1k 0.8× 353 31.0k
F. Xavier Bosch Spain 84 33.5k 1.1× 15.3k 1.1× 8.7k 1.1× 8.0k 1.2× 4.4k 0.9× 298 44.4k
Philip E. Castle United States 76 21.6k 0.7× 9.3k 0.7× 6.6k 0.8× 4.2k 0.6× 3.5k 0.7× 345 25.0k
Robert D. Burk United States 96 22.8k 0.7× 10.1k 0.7× 5.1k 0.6× 7.1k 1.1× 4.9k 1.0× 480 31.5k
Nicolas Wentzensen United States 74 16.4k 0.5× 7.7k 0.5× 6.7k 0.8× 4.7k 0.7× 2.0k 0.4× 375 24.3k
Joakim Dillner Sweden 77 20.1k 0.6× 8.0k 0.6× 7.4k 0.9× 4.3k 0.7× 3.1k 0.7× 576 27.6k
Peter J.F. Snijders Netherlands 96 32.4k 1.0× 15.6k 1.1× 10.0k 1.2× 11.3k 1.7× 5.0k 1.0× 397 43.8k
Eduardo L. Franco Canada 83 19.8k 0.6× 8.9k 0.6× 6.1k 0.8× 3.4k 0.5× 2.7k 0.6× 542 27.9k
Chris J.L.M. Meijer Netherlands 120 46.1k 1.5× 22.3k 1.6× 16.6k 2.0× 14.5k 2.2× 7.7k 1.6× 799 68.9k
Allan Hildesheim United States 86 14.6k 0.5× 6.6k 0.5× 5.5k 0.7× 4.3k 0.7× 2.4k 0.5× 338 22.6k

Countries citing papers authored by Mark Schiffman

Since Specialization
Citations

This map shows the geographic impact of Mark Schiffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Schiffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Schiffman more than expected).

Fields of papers citing papers by Mark Schiffman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Schiffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Schiffman. The network helps show where Mark Schiffman may publish in the future.

Co-authorship network of co-authors of Mark Schiffman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Schiffman. A scholar is included among the top collaborators of Mark Schiffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Schiffman. Mark Schiffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desai, Kanan, Sílvia de Sanjosé, & Mark Schiffman. (2023). Treatment of Cervical Precancers is the Major Remaining Challenge in Cervical Screening Research. Cancer Prevention Research. 16(12). 649–651. 4 indexed citations
2.
Inturrisi, Federica, Sílvia de Sanjosé, Kanan Desai, et al.. (2023). A rapid HPV typing assay to support global cervical cancer screening and risk‐based management: A cross‐sectional study. International Journal of Cancer. 154(2). 241–250. 17 indexed citations
3.
Perkins, Rebecca B., José Jerónimo, Anne Hammer, et al.. (2022). Comparison of accuracy and reproducibility of colposcopic impression based on a single image versus a two-minute time series of colposcopic images. Gynecologic Oncology. 167(1). 89–95. 9 indexed citations
4.
Lou, Hong, Joseph F. Boland, Weiyin Zhou, et al.. (2020). The D2 and D3 Sublineages of Human Papilloma Virus 16–Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis. Cancer Research. 80(18). 3803–3809. 8 indexed citations
5.
Clarke, Megan A., Ana Gradíssimo, Mark Schiffman, et al.. (2018). Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women. Clinical Cancer Research. 24(9). 2194–2202. 77 indexed citations
6.
Silver, Michelle I., Julia C. Gage, Mark Schiffman, et al.. (2018). Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21–39 Years. Cancer Prevention Research. 11(3). 165–170. 31 indexed citations
7.
Kuhs, Krystle A. Lang, Xing Hua, Mark Schiffman, et al.. (2018). T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study. PLoS ONE. 13(1). e0178167–e0178167. 12 indexed citations
8.
Panagiotou, Orestis A., Brian Befano, Paula González, et al.. (2015). Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial. BMJ. 351. h4358–h4358. 31 indexed citations
9.
Schiffman, Mark, Seán Boyle, Tina Raine‐Bennett, et al.. (2015). The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test. Cancer Epidemiology Biomarkers & Prevention. 24(9). 1304–1310. 40 indexed citations
10.
Gage, Julia C., William C. Hunt, Mark Schiffman, et al.. (2015). Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program. Cancer Epidemiology Biomarkers & Prevention. 25(1). 36–42. 15 indexed citations
11.
Boon, Johan A. den, Dohun Pyeon, Sophia Wang, et al.. (2015). Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proceedings of the National Academy of Sciences. 112(25). E3255–64. 222 indexed citations
12.
Gage, Julia C., Mark Schiffman, Diane Solomon, et al.. (2013). Risk of Precancer Determined by HPV Genotype Combinations in Women with Minor Cytologic Abnormalities. Cancer Epidemiology Biomarkers & Prevention. 22(6). 1095–1101. 20 indexed citations
13.
Schiffman, Mark, Andrew G. Glass, Nicolas Wentzensen, et al.. (2011). A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 20(7). 1398–1409. 106 indexed citations
14.
Herrero, Rolando, Sholom Wacholder, Ana Cecilia Rodríguez, et al.. (2011). Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica. Cancer Discovery. 1(5). 408–419. 116 indexed citations
15.
Schiffman, Mark, Nicolas Wentzensen, Sholom Wacholder, et al.. (2011). Human Papillomavirus Testing in the Prevention of Cervical Cancer. JNCI Journal of the National Cancer Institute. 103(5). 368–383. 554 indexed citations breakdown →
16.
Wentzensen, Nicolas, Lauren E. Wilson, Cosette M. Wheeler, et al.. (2010). Hierarchical Clustering of Human Papilloma Virus Genotype Patterns in the ASCUS-LSIL Triage Study. Cancer Research. 70(21). 8578–8586. 23 indexed citations
17.
Kemp, Troy J., Allan Hildesheim, Alfonso Garcı́a-Piñeres, et al.. (2010). Elevated Systemic Levels of Inflammatory Cytokines in Older Women with Persistent Cervical Human Papillomavirus Infection. Cancer Epidemiology Biomarkers & Prevention. 19(8). 1954–1959. 68 indexed citations
18.
Castle, Philip E., Ana Cecilia Rodríguez, Robert D. Burk, et al.. (2009). Neither one‐time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer. International Journal of Cancer. 125(7). 1649–1656. 14 indexed citations
19.
Cox, J. Thomas, Mark Schiffman, & Diane Solomon. (2003). Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. American Journal of Obstetrics and Gynecology. 188(6). 1406–1412. 265 indexed citations
20.
Schiffman, Mark, Rolando Herrero, Allan Hildesheim, et al.. (2001). HPV DNA Testing in Cervical Cancer Screening: Results from Women in a High‐Risk Province of Costa Rica. Journal of Lower Genital Tract Disease. 5(1). 56–57. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rolando Herrero Breakdown of academic impact, for papers by F. Xavier Bosch Breakdown of academic impact, for papers by Philip E. Castle Breakdown of academic impact, for papers by Robert D. Burk Breakdown of academic impact, for papers by Nicolas Wentzensen Breakdown of academic impact, for papers by Joakim Dillner Breakdown of academic impact, for papers by Peter J.F. Snijders Breakdown of academic impact, for papers by Eduardo L. Franco Breakdown of academic impact, for papers by Chris J.L.M. Meijer Breakdown of academic impact, for papers by Allan Hildesheim
Rankless by CCL
2026